The UK Interstitial Lung Disease Long-COVID19 Study (UKILD-Long COVID): Understanding the Burden of Interstitial Lung Disease in Long COVID.
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
Prospective observational study of hospitalised and non-hospitalised patients post- infection with SARS-CoV-2. The study aims to recruit 2000 individuals, with proven COVID-19, who were not hospitalised but presented to Long-COVID clinics with persistent respiratory symptoms such as breathlessness or cough and are referred for cross-sectional imaging (computer tomography, CT) at baseline (3 months weeks after their first COVID-19 symptoms). The study will run for 18 months.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 99
View:
• Age \>18 years old -99 years old
• Evidence of SARS-CoV-2 infection confirmed by PCR or serology 3 months (+/- 6 weeks) earlier
• Clinical indication for a chest CT scan as per clinician judgment
Locations
Other Locations
United Kingdom
Imperial College Healthcare trust
RECRUITING
London
Contact Information
Primary
mark weeks, Dr
m.weeks@imperial.ac.uk
+44 (0)20 7594 7972
Time Frame
Start Date: 2021-08-18
Estimated Completion Date: 2024-03-31
Participants
Target number of participants: 2000
Related Therapeutic Areas
Sponsors
Collaborators: University of Oxford, University of Leicester, Medical Research Council, University of Newcastle Upon-Tyne, University of Nottingham, University of Liverpool, University of Sheffield, University of Manchester, University College, London, University of Southampton, University of Edinburgh
Leads: Imperial College London